Better formulations improve access, affordability and the quality of care.
Every formulation decision has a downstream effect — on cost, on safety, on the minutes a nurse spends preparing a dose. We design for all three.
Differentiated formulations of known, well-understood molecules move through inherently more capital-efficient development pathways than novel chemical entities — supporting pricing and access that first-in-class development often cannot.
Ready-to-use and pre-filled formats are designed to remove manual preparation steps — and the errors, contamination risk, and dosing variability that can come with them.
Fewer reconstitution and preparation steps mean clinical staff spend less time preparing doses — time that returns to patients, not procedure.
Lyophilised and stabilized formulations are designed to extend shelf life and reduce variability, supporting more predictable administration and supply in clinical settings.
Formulation complexity is our problem to solve — so it stops being everyone else's.